Citations refer to the original publication, not to a Scieee localized version.
Molinos-Quintana, Á., Alonso-Saladrigues, A., Herrero, B., Caballero Velázquez, T., Galán-Gómez, V., Panesso, M., & Pérez Simón, J. A. (2024). Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring. Frontiers. https://doi.org/10.3389/fimmu.2024.1373852
Molinos-Quintana, Águeda, et al. Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring. Frontiers, 2024. https://doi.org/10.3389/fimmu.2024.1373852.
Molinos-Quintana, Águeda, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero Velázquez, Víctor Galán-Gómez, Melissa Panesso, and José Antonio Pérez Simón. Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring. Frontiers, 2024. https://doi.org/10.3389/fimmu.2024.1373852.
Molinos-Quintana, Á. et al. (2024) Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring. Frontiers. Available at: https://doi.org/10.3389/fimmu.2024.1373852.
Á. Molinos-Quintana et al., “Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring,” Frontiers, 2024, doi: 10.3389/fimmu.2024.1373852.
@misc{molinosquintana2024corrigendum,
author = {Molinos-Quintana, Águeda and Alonso-Saladrigues, Anna and Herrero, Blanca and Caballero Velázquez, Teresa and Galán-Gómez, Víctor and Panesso, Melissa and Pérez Simón, José Antonio},
title = {Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring},
year = {2024},
publisher = {Frontiers},
doi = {10.3389/fimmu.2024.1373852},
url = {https://doi.org/10.3389/fimmu.2024.1373852}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
